Table 1—

Clinical, laboratory characteristics, and lipid profile of type 2 diabetic patients

NormoalbuminuricMicroalbuminuricP
n3735
Age (years)58.9 ± 10.156.0 ± 9.30.207
Gender (male)18 (48.6)20 (57.1)0.490
Diabetes duration (years)10.6 ± 7.511.5 ± 7.70.650
Hypertension21 (56.8)22 (62.9)0.637
Diabetes treatment (D/OA/I/I+OA)5/28/0/42/16/7/100.003
BMI (kg/m2)26.4 ± 3.527.9 ± 2.70.052
Fasting plasma glucose (mg/dl)121 ± 34124 ± 320.698
Fructosamine (mmol/l)3.07 ± 0.543.39 ± 0.540.015
GHb (%)4.97 ± 0.785.50 ± 1.280.041
Serum creatinine (mg/dl)0.87 ± 0.190.88 ± 0.180.587
24 h UAER (μg/min)6.38 (3.78–7.66)51.4 (31.9–81.4)
Apolipoprotein B (mg/dl)114 ± 31124 ± 300.177
Cholesterol (mg/dl)196 ± 39203 ± 350.432
Triglycerides (mg/dl)120 (92–195)122 (88–175)0.818
HDL (mg/dl)52 ± 2049 ± 160.572
HDL2 (mg/dl)14 ± 1311 ± 120.342
HDL3 (mg/dl)37 ± 1538 ± 130.740
LDL (mg/dl)113 ± 32124 ± 290.157
Non-HDL cholesterol (mg/dl)144 ± 39153 ± 350.305
Cholesterol/HDL ratio4.22 ± 1.614.36 ± 1.050.672
  • Data are expressed as mean ± SD, median (95% CI), or number of patients (%) with the characteristic. D/OA/I/I+OA, diet only/oral antidiabetic agents/insulin/insulin associated with oral antidiabetic agent.